203 related articles for article (PubMed ID: 21068439)
1. Development of severe skeletal defects in induced SHP-2-deficient adult mice: a model of skeletal malformation in humans with SHP-2 mutations.
Bauler TJ; Kamiya N; Lapinski PE; Langewisch E; Mishina Y; Wilkinson JE; Feng GS; King PD
Dis Model Mech; 2011 Mar; 4(2):228-39. PubMed ID: 21068439
[TBL] [Abstract][Full Text] [Related]
2. Deletion of SHP-2 in mesenchymal stem cells causes growth retardation, limb and chest deformity, and calvarial defects in mice.
Lapinski PE; Meyer MF; Feng GS; Kamiya N; King PD
Dis Model Mech; 2013 Nov; 6(6):1448-58. PubMed ID: 24077964
[TBL] [Abstract][Full Text] [Related]
3. Receptor activator of NF-kappa B ligand stimulates recruitment of SHP-1 to the complex containing TNFR-associated factor 6 that regulates osteoclastogenesis.
Zhang Z; Jimi E; Bothwell AL
J Immunol; 2003 Oct; 171(7):3620-6. PubMed ID: 14500659
[TBL] [Abstract][Full Text] [Related]
4. Regulation of bone and skeletal development by the SHP-2 protein tyrosine phosphatase.
Kamiya N; Kim HK; King PD
Bone; 2014 Dec; 69():55-60. PubMed ID: 25178522
[TBL] [Abstract][Full Text] [Related]
5. Ptpn11 deletion in a novel progenitor causes metachondromatosis by inducing hedgehog signalling.
Yang W; Wang J; Moore DC; Liang H; Dooner M; Wu Q; Terek R; Chen Q; Ehrlich MG; Quesenberry PJ; Neel BG
Nature; 2013 Jul; 499(7459):491-5. PubMed ID: 23863940
[TBL] [Abstract][Full Text] [Related]
6. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
7. The tyrosine phosphatase SHP-1 is a negative regulator of osteoclastogenesis and osteoclast resorbing activity: increased resorption and osteopenia in me(v)/me(v) mutant mice.
Aoki K; Didomenico E; Sims NA; Mukhopadhyay K; Neff L; Houghton A; Amling M; Levy JB; Horne WC; Baron R
Bone; 1999 Sep; 25(3):261-7. PubMed ID: 10495129
[TBL] [Abstract][Full Text] [Related]
8. Human somatic PTPN11 mutations induce hematopoietic-cell hypersensitivity to granulocyte-macrophage colony-stimulating factor.
Chan RJ; Leedy MB; Munugalavadla V; Voorhorst CS; Li Y; Yu M; Kapur R
Blood; 2005 May; 105(9):3737-42. PubMed ID: 15644411
[TBL] [Abstract][Full Text] [Related]
9. Deficiency of SHP-1 protein-tyrosine phosphatase activity results in heightened osteoclast function and decreased bone density.
Umeda S; Beamer WG; Takagi K; Naito M; Hayashi S; Yonemitsu H; Yi T; Shultz LD
Am J Pathol; 1999 Jul; 155(1):223-33. PubMed ID: 10393854
[TBL] [Abstract][Full Text] [Related]
10. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
Cai X; Xing J; Long CL; Peng Q; Humphrey MB
J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
[TBL] [Abstract][Full Text] [Related]
11. Loss of MMP-2 disrupts skeletal and craniofacial development and results in decreased bone mineralization, joint erosion and defects in osteoblast and osteoclast growth.
Mosig RA; Dowling O; DiFeo A; Ramirez MC; Parker IC; Abe E; Diouri J; Aqeel AA; Wylie JD; Oblander SA; Madri J; Bianco P; Apte SS; Zaidi M; Doty SB; Majeska RJ; Schaffler MB; Martignetti JA
Hum Mol Genet; 2007 May; 16(9):1113-23. PubMed ID: 17400654
[TBL] [Abstract][Full Text] [Related]
12. Altered hematopoiesis in glypican-3-deficient mice results in decreased osteoclast differentiation and a delay in endochondral ossification.
Viviano BL; Silverstein L; Pflederer C; Paine-Saunders S; Mills K; Saunders S
Dev Biol; 2005 Jun; 282(1):152-62. PubMed ID: 15936336
[TBL] [Abstract][Full Text] [Related]
13. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.
Kanazawa K; Kudo A
J Bone Miner Res; 2005 May; 20(5):840-7. PubMed ID: 15824857
[TBL] [Abstract][Full Text] [Related]
14. Role of CSF-1 in bone and bone marrow development.
Cecchini MG; Hofstetter W; Halasy J; Wetterwald A; Felix R
Mol Reprod Dev; 1997 Jan; 46(1):75-83; discussion 83-4. PubMed ID: 8981367
[TBL] [Abstract][Full Text] [Related]
15. Noonan syndrome/leukemia-associated gain-of-function mutations in SHP-2 phosphatase (PTPN11) enhance cell migration and angiogenesis.
Wang S; Yu WM; Zhang W; McCrae KR; Neel BG; Qu CK
J Biol Chem; 2009 Jan; 284(2):913-20. PubMed ID: 19008228
[TBL] [Abstract][Full Text] [Related]
16. In vitro differentiation of CD14 cells from osteopetrotic subjects: contrasting phenotypes with TCIRG1, CLCN7, and attachment defects.
Blair HC; Borysenko CW; Villa A; Schlesinger PH; Kalla SE; Yaroslavskiy BB; Garćia-Palacios V; Oakley JI; Orchard PJ
J Bone Miner Res; 2004 Aug; 19(8):1329-38. PubMed ID: 15231021
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a novel tyrosine phosphorylated 100-kDa protein that binds to SHP-2 and phosphatidylinositol 3'-kinase in myeloid cells.
Carlberg K; Rohrschneider LR
J Biol Chem; 1997 Jun; 272(25):15943-50. PubMed ID: 9188495
[TBL] [Abstract][Full Text] [Related]
18. The SH2 domain-containing protein tyrosine phosphatase SHP-1 is induced by granulocyte colony-stimulating factor (G-CSF) and modulates signaling from the G-CSF receptor.
Ward AC; Oomen SP; Smith L; Gits J; van Leeuwen D; Soede-Bobok AA; Erpelinck-Verschueren CA; Yi T; Touw IP
Leukemia; 2000 Jul; 14(7):1284-91. PubMed ID: 10914554
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 17 regulates SHP-2 and IL-17RA/STAT-3 dependent Cyr61, IL-23 and GM-CSF expression and RANKL mediated osteoclastogenesis by fibroblast-like synoviocytes in rheumatoid arthritis.
Ganesan R; Rasool M
Mol Immunol; 2017 Nov; 91():134-144. PubMed ID: 28898718
[TBL] [Abstract][Full Text] [Related]
20. Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis.
Koga T; Inui M; Inoue K; Kim S; Suematsu A; Kobayashi E; Iwata T; Ohnishi H; Matozaki T; Kodama T; Taniguchi T; Takayanagi H; Takai T
Nature; 2004 Apr; 428(6984):758-63. PubMed ID: 15085135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
